Trial Profile
A Phase 1, Three-Part, Three-Period, Open-Label, Randomized, Single Dose, Crossover Interaction Study, in Healthy Male Subjects to Investigate the Potential for a Pharmacokinetic Drug-Drug Interaction After Co-Administration of DS-5565 and Metformin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary) ; Metformin
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 27 Jul 2018 Results assessing safety and tolerabilty published in the International Journal of Clinical Pharmacology and Therapeutics
- 20 May 2017 Results presented at the 36th Annual Scientific Meeting of the American Pain Society
- 19 Feb 2014 New trial record